Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure

Nat Commun. 2020 Aug 31;11(1):4364. doi: 10.1038/s41467-020-18128-x.

Abstract

Pathophysiological roles of cardiac dopamine system remain unknown. Here, we show the role of dopamine D1 receptor (D1R)-expressing cardiomyocytes (CMs) in triggering heart failure-associated ventricular arrhythmia. Comprehensive single-cell resolution analysis identifies the presence of D1R-expressing CMs in both heart failure model mice and in heart failure patients with sustained ventricular tachycardia. Overexpression of D1R in CMs disturbs normal calcium handling while CM-specific deletion of D1R ameliorates heart failure-associated ventricular arrhythmia. Thus, cardiac D1R has the potential to become a therapeutic target for preventing heart failure-associated ventricular arrhythmia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arrhythmias, Cardiac / etiology*
  • Arrhythmias, Cardiac / prevention & control
  • Gene Expression Profiling / methods
  • Heart Failure*
  • Humans
  • Mice
  • Mice, Transgenic
  • Myocytes, Cardiac / metabolism*
  • Rats
  • Receptors, Dopamine D1 / genetics
  • Receptors, Dopamine D1 / metabolism*
  • Sequence Analysis, RNA / methods
  • Single-Cell Analysis / methods
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / prevention & control

Substances

  • DRD1 protein, human
  • Receptors, Dopamine D1